Posts

November 13, 2014

+
5:23 PM | A sharper focus on branding
How does a highly-effective brand team differ from the industry standard?
+
5:09 PM | NHS names drugs to be re-evaluated for Cancer Drugs Fund
Will assess cost-effectiveness of drugs including Kadcyla and Avastin
+
2:49 PM | When Mutation Counters Infection: From Sickle Cell to Ebola
 While pharmaceutical companies focus on drug discovery for Ebola virus disease, a powerful clue is coming from a rare “Jewish genetic disease” that destroys the brain. People with Niemann-Pick C1 disease can’t get Ebola, adding to the list of disease … Continue reading »The post When Mutation Counters Infection: From Sickle Cell to Ebola appeared first on DNA Science Blog.
+
1:42 PM | What’s The Answer? (mobile bioinformatics apps)
Biostars is a site for asking, answering and discussing bioinformatics questions and issues. We are members of the community and find it very useful. Often questions and answers arise at Biostars that are germane to our readers (end users of genomics resources). Every Thursday we will be highlighting one of those items or discussions here […]
+
1:00 PM | Revolution and reimbursement in the cell therapy industry
. With contributions from James Smith, a recent Oxford University graduate and current CASMI Translational Stem Cell Consortium Research Associate   In the early 1770s, Britain faced a significant financial dilemma. One of its most important commercial institutions, the East India Company, had come into considerable financial problems; a large quantity of tea was being...Read more
+
11:37 AM | Allergan 'close' to $60bn takeover agreement with Actavis
If successful the negotiations would scupper Valeant's hostile bid
+
11:34 AM | Servier licenses device that could 'reshape' diabetes care
Tiny pump implant to deliver GLP-1 agonist
+
11:22 AM | Eylea's UK launch earns Bayer PMEA success
Receives the Cello Health Award for Launch Excellence
+
12:16 AM | inVentiv adds Joanne Wunder to leadership team
Joins PR unit Biosector 2
+
12:01 AM | Using humour in healthcare marketing
Is laughter the best medicine?

November 12, 2014

+
9:28 PM | Eisai's cancer cookbook wins CSR award
Around the Kitchen Table project see success at PMEA 2014
+
9:28 PM | Eylea UK launch earns Bayer PMEA success
Receives the Cello Health Award for Launch Excellence
+
9:27 PM | AbbVie takes home company of the year at PMEA 2014
Firm is rewarded for its patient-focus
+
7:28 PM | Taming Cheating Cells Gives Rise to Spectacular Evolution
All multicellular creatures are descended from single-celled organisms. The leap from unicellularity to multicellularity is possible only if the originally independent cells collaborate. So-called cheating cells that exploit the cooperation of others are considered a major obstacle. Scientists at the Max Planck Institute for Evolutionary Biology in Plön, Germany, together with researchers from New Zealand […]
+
5:10 PM | A Breath of Fresh Air in the Study of Epigenetics and Asthma
According to a study conducted by the CDC in 2009, 1 in 12 Americans has asthma. This marks a 1% increase in affected population since 2001. Asthma is a complex disease involving multiple pathways, causing symptoms such as wheezing, chest tightness, shortness of breath, and coughing. In different patients these ... The post A Breath of Fresh Air in the Study of Epigenetics and Asthma appeared first on EpiBeat.
+
4:57 PM | Optimizing Tryptic Digestions for Phosphoproteomics Analysis
Protein phosphorylation is the most widespread type of post-translational modification. It affects every basic cellular process, including metabolism, growth, division, differentiation, motility, organelle trafficking, membrane transport, muscle contraction, immunity, learning and memory (1,2). Protein kinases catalyse the transfer of the phosphate from ATP to specific amino acids in proteins. In eukaryotes, these are usually Ser, […]
+
3:29 PM | “The GMO Deception” is, in fact, deceptive
Recycling can be a very good practice. Re-using components of electronics, waste paper, and food scraps that would otherwise head to the waste stream can be a great idea. However, sometimes re-use doesn’t bring any value. Recycling bad claims and ideas about GMOs helps no one. Unfortunately, The GMO Deception is a prime example of worthless recycling. A stale and misleading text worth only about 2 pounds of recycled paper. I found out about this text from Marion Nestle’s blog. She […]
+
1:08 PM | Video Tip of the Week: UpSet about genomics Venn Diagrams?
Who can forget the Banana Venn? It was one of the most talked-about visualizations in genomics that I’m aware of. A new concept in data visualization: the Venn/banana diagram. MT @phylogenomics http://t.co/xjitNDNl — Iddo Friedberg (@iddux) July 19, 2012 Banana? RT @phylogenomics: Perhaps the best genomics Venn diagram ever #Bananas #NotSureWhatItMeansButDontCare http://t.co/xMV25GBG — Brian Kent […]

D’Hont A., Jean-Marc Aury, Franc-Christophe Baurens, Françoise Carreel, Olivier Garsmeur, Benjamin Noel, Stéphanie Bocs, Gaëtan Droc, Mathieu Rouard & Corinne Da Silva & (2012). The banana (Musa acuminata) genome and the evolution of monocotyledonous plants, Nature, 488 (7410) 213-217. DOI: http://dx.doi.org/10.1038/nature11241

Lex A., Gehlenborg N., Strobelt H., Vuillemot R.V. & Pfister H. (2014). UpSet: Visualization of Intersecting Sets, IEEE Transactions on Visualization and Computer Graphics (InfoVis '14), Other:

Lex A. (2014). Points of view: Sets and intersections, Nature Methods, 11 (8) 779-779. DOI: http://dx.doi.org/10.1038/nmeth.3033

Gibbs R.A., Michael L. Metzker, Donna M. Muzny, Erica J. Sodergren, Steven Scherer, Graham Scott, David Steffen, Kim C. Worley, Paula E. Burch & Geoffrey Okwuonu & (2004). Genome sequence of the Brown Norway rat yields insights into mammalian evolution, Nature, 428 (6982) 493-521. DOI: http://dx.doi.org/10.1038/nature02426

Citation
+
11:13 AM | Takeda enlists GE's aid to tackle liver fibrosis epidemic
Non-alcoholic liver disease has doubled in the last 20 years
+
10:22 AM | Amgen and AZ's psoriasis antibody beats Stelara in study
Brodalumab cleared all skin lesions in 37% compared to Stelara’s 18.5%
+
10:12 AM | NICE wants more evidence on skin damage technologies
But ‘spray-on-skin’ and clothes to prevent ulcers can still be used on NHS
+
1:50 AM | Novartis to deliver three million malaria treatments in Zambia
Part of Malaria No More’s Power of One campaign
+
12:16 AM | ROCK names new managing director
Terence Bradley is founding director of Pollen Health
+
12:15 AM | Zealand adds two observers to board of directors
Martin Nicklasson and Catherine Moukheibir join the firm
+
12:15 AM | Novo taps behavioural change for diabetes programme’s re-launches
Adds health coach function to Cornerstones4Care

November 11, 2014

+
10:23 PM | Worldwide vaccine uptake-2014
I make it a point to update this blog with the most current CDC analysis of vaccine uptake in the USA for kindergarten children (usually around 5 years old). Generally, the numbers have stayed stable, at around 95% vaccinated, although there is high variance from state to state, and locality to locality. The weakness in […]Continue reading «Worldwide vaccine uptake-2014»
+
5:25 PM | European Commission forms €2.5bn big data partnership
Says mastering data will lead to better health outcomes
+
2:49 PM | The Coming Crisis in Antibiotics
Tweet This Post
+
12:10 PM | SMC fails to recommend Roche’s Perjeta
Says drug is not a cost-effective option in breast cancer
+
10:45 AM | Dendreon files for bankruptcy protection
Follows poor sales of cancer vaccine Provenge
123456789
291 Results